Influenza Antiviral Drugs and Patent Law Issues

Format:

Book

Government document

Author/Creator:

Library of Congress. Congressional Research Service

Language:

English

Subjects (All):

Influenza.

Negotiation.

Patents.

Physical Description:

1 online resource

Contained In:

ProQuest U.S. Congressional Research Digital Collection

Place of Publication:

[Place of publication not identified] [publisher not identified] 2007

Summary:

Identifies and analyzes aspects of patent law affecting the availability and affordability of avian influenza antiviral medications such as the vaccine Tamiflu, produced by Roche, Incorporated Examines legal options for increasing Tamiflu drug production, including the use of compulsory licensing under the Agreement on Trade-Related Aspects of Intellectual Property Rights and U.S. Code, and through sublicensing agreements voluntarily negotiated by Roche, Incorporated, with third-parties of its choosing

Notes:

CRS Report

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC

Vendor supplied data

Other Format:

Microfiche version Library of Congress Congressional Research Service Influenza Antiviral Drugs and Patent Law Issues

Publisher Number:

CRS-2007-AML-0360

Access Restriction:

Restricted for use by site license